Minnesota’s winter illness season, typically spanning from October to May, brings a surge in respiratory viruses like the flu, COVID-19 and respiratory syncytial virus (RSV). With frigid temperatures ...
Abbott Laboratories fell on its latest earnings report, but I view this as a buying opportunity. Read the latest analysis on ...
Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine - which designs nanotechnology-based platforms for clinical translation across specialties - developed a ...
GoodRx reports on tracking prescription fills for flu and COVID-19 treatments, revealing seasonal trends and insurance ...
Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...
Though deaths linked to cardiovascular diseases are down, stroke and heart disease are still in the top five leading causes ...
Overuse of antibiotics has accelerated the development of bacterial resistance to conventional drugs, a global health crisis ...
A state lawmaker wants the South Dakota Legislature to address how ivermectin and hydroxychloroquine are dispensed to ...
New options for testing and treating some of the most common sexually transmitted diseases are becoming available, a trend that experts hope will keep downward pressure on U.S. infection ...
NEW HAVEN, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) and the SPEAR Study Group today announced the plan to initiate a Phase 2 clinical trial evaluating monoclonal antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback